Advertisement

Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • National Center for Complementary and Alternative Medicine
        Wfhat is Complementary and Alternative Medicine?.
        (Available at:) (Accessed March 10, 2009)
        • Tindle HA
        • Davis RB
        • Phillips RS
        • Eisenberg DM
        Trends in use of complementary and alternative medicine by US adults: 1997–2002.
        Altern Ther Health Med. 2005; 11: 42-49
        • Ni H
        • Simile C
        • Hardy AM
        Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey.
        Med Care. 2002; 40: 353-358
        • Eisenberg DM
        • Davis RB
        • Ettner SL
        • et al.
        Trends in alternative medicine use in the United States, 1990–1997: results ofa follow-up national survey.
        JAMA. 1998; 280: 1569-1575
        • Kogan NM
        • Mechoulam R
        Cannabinoids in health and disease.
        Dialogues Clin Neurosci. 2007; 9: 413-430
        • Hepler RS
        • Frank IR
        Marihuana smoking and intraocular pressure.
        JAMA. 1971; 217: 1392
        • Form B2
        Medical practitioner’s form for category 2 applicants.
        (Available at:) (Accessed April 26, 2010)
      1. Canadian Ophthalmological Society policy statement on the medical use of marijuana forfor glaucoma.
        (Available at:) (Accessed April 26, 2010)
        • Zias J
        • Stark H
        • Sellgman J
        • et al.
        Early medical use of cannabis.
        Nature. 1993; 363: 215
        • Gaoni Y
        • Mechoulam R
        Isolation, structure and partial synthesis of the active constituent of hashish.
        J Am Chem Soc. 1964; 86: 1646-1647
        • Merritt JC
        • Crawford WJ
        • Alexander PC
        • Anduze AL
        • Gelbart SS
        Effect of marihuana on intraocular and blood pressure in glaucoma.
        Ophthalmology. 1980; 87: 222-2228
        • Merritt JC
        • McKinnon S
        • Armstrong JR
        • Hatem G
        • Reid LA
        Oral delta 9-tetrahydrocannabinol in heterogeneous glaucomas.
        Ann Ophthalmol. 1980; 12: 947-950
        • Purnell WD
        • Gregg JM
        Delta(9)-tetrahydrocannabinol, euphoria and intraocular pressure in man.
        Ann Ophthalmol. 1975; 7: 921-923
        • Tomida I
        • Azuara-Blanco A
        • House H
        • Fling M
        • Pertwee RG
        • Robson PJ
        Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
        J Glaucoma. 2006; 15: 349-353
        • Merritt JC
        • Olsen JL
        • Armstrong JR
        • McKinnon SM
        Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
        J Pharm Pharmacol. 1981; 33: 40-41
        • Green K
        • Roth M
        Oculareffectsoftopicaladministrationof delta 9-tetrahydrocannabinol in man.
        Arch Ophthalmol. 1982; 100: 265-267
        • Jay WM
        • Green K
        Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.
        Arch Ophthalmol. 1983; 101: 591-593
        • Green K
        • Podos SM
        Antagonism ofarachidonic acid-induced ocular effects by D1-tetrahydrocannabinol.
        Invest Ophthalmol. 1974; 13: 422-429
        • Porcella A
        • Casellas P
        • Gessa GL
        • Pani L
        Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana.
        Brain Res Mol Brain Res. 1998; 58: 240-245
        • Zhan GL
        • Camras CB
        • Palmber PF
        • Toris CB
        Effects ofmari-juana on aqueous humor dynamics in a glaucoma patient.
        J Glaucoma. 2005; 14: 175-177
        • Brown B
        • Adams AJ
        • Haegerstrom-Portnoy G
        • Jones RT
        • Flom MC
        Pupil size after use of marijuana and alcohol.
        Am J Ophthalmol. 1977; 83: 350-354
        • Hashibe M
        • Ford DE
        • Zhang ZF
        Marijuana smoking and head and neck cancer.
        J ClinPharmacol. 2002; 42: 103S-107S
        • Flom MC
        • Adams AJ
        • Jones RT
        Marijuana smoking and reduced pressure in human eyes: drug action or epiphen-omenon?.
        Invest Ophthalmol. 1975; 14: 52-55